Table 5.

Distribution of Subjects with and without Clinically Significant Diabetic Macular Edema (CSDME) After 12 Months of Different Treatment Groups

Presence or Absence of CSDME	RBZ+Laser Treated Group	BVZ+Laser Treated Group	p-value
Presence	28 (36.36%)	22 (43.13%)	0.464
Absence	49 (63.63%)	29 (56.86%)

Notes: Categorical variables in two groups were presented as percentages (%) and compared by the Chi-Square test. In the RBZ + Laser treated group 28 (36.36%) and 49 (63.63%) subjects were found with CSME and without CSDME respectively after 12 months. In the BVZ+Laser treated group 22 (43.13%) and 29 (56.86%) subjects were found with CSDME and without CSDME respectively after 12 months. The statistical analysis showed no statistical difference in subjects distribution between the groups. A value of p < 0.05 was considered statistically significant.